The company develops an mRNA Lightning platform that combines mRNA biology with AI imaging to visualize the entire life cycle of mRNA in cells. This platform decodes mRNA biology underlying diseases and screens optimized mRNA modulator libraries to identify drug candidates.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for visualizing mRNA's lifecycle within cells are limited, hindering the understanding of mRNA's role in disease and the development of targeted mRNA-based therapeutics. Existing technologies lack the ability to comprehensively track and analyze the entire mRNA process in a cellular environment.
Solution
The company offers an integrated platform combining mRNA biology with advanced AI imaging to visualize the complete lifecycle of mRNA within cells. This platform enables researchers to decode the complexities of mRNA biology in the context of various diseases. By using this platform, scientists can screen optimized mRNA modulator libraries to identify and develop potential drug candidates that target specific mRNA processes. The platform provides a detailed view of mRNA behavior, facilitating a deeper understanding of disease mechanisms and accelerating drug discovery.
Target Audience
The primary audience includes pharmaceutical companies, biotechnology firms, and academic research institutions focused on mRNA-based therapeutics and disease research.
Features
- High-resolution imaging of mRNA localization, translation, and degradation in cells.
- AI-powered image analysis for automated quantification of mRNA dynamics.
- Optimized mRNA modulator libraries for screening potential therapeutic candidates.
- Integrated data visualization tools for comprehensive analysis of mRNA behavior.
- Customizable experimental design to study mRNA in various disease models.